JNEXT

 

UP TO 4 MILLION₪ FOR LIFE-SCIENCE COMPANIES 

 

The Jerusalem Development Authority offers a unique set of grants and financial benefits for emerging life science companies operating in Jerusalem. We are fully aware that financing a start-up is not an easy task, especially in the biotech industry. We therefore offer grants and benefits in particular to help start and grow life science companies in Jerusalem.

Over the past few years, we have approved grants of more than 30 million shekels for life science companies in the city. We welcome you to learn more about the benefits available, and we are here to assist you and your company with the process and answer with any questions that you may have.

 

A more in-depth look at the benefits offered:

 

GROW YOUR TEAM: BIOTECH COMPANIES

Jerusalem-based life science or bio-tech companies or those who are relocating to the city are entitled to grants for their employees of up to 4 million ₪.

 

  • Who is eligible?

Life science and bio-tech companies registered in Israel, employing up to 80 people and based in or relocating to Jerusalem.

  • What is the benefit?

In accordance with the grant’s terms, for each eligible employee, the company may receive a grant of 100,000₪ if the employee lives in Jerusalem, or 80,000₪ if the employee lives outside of Jerusalem.

The grant is available for up to a maximum of 40 employees, with a maximum total grant of up to 4 million₪.

Companies may receive an additional grant of 50,000₪ for employees who are students.

  • Important note

There is not a specific date by which to apply, as applications for the grant may be made on a rolling basis at any time during the year.

The grant is awarded over an eighteen-month period. Grantees will be paid 50% upon receiving authorization, 25%, six months later, and the remaining 25% at the end of the period.

The grant is not paid as a loan and does not cause dilution in any way.

  • How to apply

For more information please read the guidelines in a nutshell (in Hebrew).

Please read carefully the comprehensive grant guidelines (in Hebrew).

Contact Dr. Shay Fleishon at shay@biojerusalem.org.il if you have questions or when you are ready to apply.

Read More

Welcome Grant

Life-Science and BioTech companies that have completed one of the accelerator programs in Jerusalem are entitled to a welcome grant of 15,000 ₪ towards renting their first office space in Jerusalem.

 

  • Who is eligible?

Eligible grantees are new companies that have participated in and completed one of the accelerator programs in Jerusalem and wish to rent or are already renting their first office in Jerusalem (including designated shared spaces).

In addition, the company must have a rental contract for an office or approved shared workspace in Jerusalem for at least six months from the application date.

  • About the benefit

The company is entitled to a grant of 15,000₪ which is awarded over a six-month period.

  • Important note

There is not a specific date by which to apply by, as applications for the grant may be made on a rolling basis at any time during the year.

The grant is not paid as a loan and does not cause dilution in any way.

  • How to apply

For more information please read the guidelines in a nutshell (in Hebrew).

Please read carefully the comprehensive grant guidelines (in Hebrew).

Contact Dr. Shay Fleishon at shay@biojerusalem.org.il if you have questions or when you are ready to apply.

Read More

Reduced Corporate Tax

High-Tech and bio-tech companies located in Jerusalem are entitled to a reduced income tax of 7.5% in contrast to most areas where the rate is set at 12%.

 

  • Who is eligible?

Companies that are under the provisions of the Encouragement of Capital Investments and located in Jerusalem are entitled to tax benefits of a reduced corporate tax rate of 7.5% instead of the regular corporate tax rate of 12%

  • What are the relevant criteria to receive this benefit?

Companies must be recognized as an Industrial and Competitive Enterprise. A Competitive Enterprise must export at least 25% of its revenues.

For more information, please consult your accountant directly.

Read More